분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2010-05-01 12:21:20 , Hit : 3003
 More support for transcription trickPosted by Jef Akst


[Entry posted at 29th April 2010 05:00 PM GMT]
Comment on this news story  

After recruiting the appropriate cellular machinery, transcription factors can further regulate gene expression by encouraging that machinery to do its job -- copy the DNA into an RNA transcript.


DNA Polymerase
Image: Wikimedia commons,
The Protein Data Bank PDB
A new study published online today (April 29) in Cell helps drive home just how widespread this second level of gene control is, and implicates a cancer-causing transcription factor as a major player in the process.

"This is another piece in the puzzle that demonstrates controlling the elongation phase of transcription" -- the production of messenger RNA as the transcriptional apparatus propagates down the gene -- "is one of the more important control mechanisms," said biochemist David Price of the University of Iowa, who was not involved in the study. "[This] paper is going to help convince the field that this is just the way it is."

Scientists once believed that transcription factors promoted gene expression simply by recruiting RNA polymerase II (Pol II) machinery to the promoter region of their target genes, and letting the Pol II take over from there. But over the last 20 years, several lines of evidence indicated that once bound to the promoter, Pol II pauses, or stalls, just a little ways down the transcript, and needs another signal (such as a transcription factor) to continue transcribing the gene. Recent evidence suggests that this pause is a widespread phenomenon in the genome, but "there's been some reluctance in the transcription community to accept that there are these polymerases poised [just past the start site] all throughout the human genome," Price said.

Exploring the role of this mechanism of gene control in mouse embryonic stem cells (ESCs), molecular biologist Richard Young of the Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology and his colleagues have all but eliminated that doubt. They found evidence of paused polymerases on the vast majority of genes -- both those actively being transcribed and those that remained silent.

"We're thinking now that at all genes where RNA polymerase II initiates transcription, there is a pause step," Young said. "So even genes that are being currently and actively transcribed, polymerase initiates [transcription], but must go through this pause checkpoint before it's allowed to proceed to elongation."

The team further showed that the well-studied transcription factor c-Myc, which is involved in cell self-renewal and proliferation and has been implicated in 15-30 percent of human cancers, is an example of the additional factor needed to push Pol II past the pause. Instead of promoting gene expression by recruiting Pol II to the genes, c-Myc appears to release already-initiated polymerases from this paused stage. It does so by recruiting a protein known as positive transcription elongation factor b (P-TEPb) to release the Pol II to finish what it started.

Understanding the details of this mechanism of gene control could thus have important implications for the treatment of a variety of ailments, said molecular biologist and clinician B. Matija Peterlin of the University of California, San Francisco, who also did not participate in the research. "I think it brings a whole new aspect to not just cancer [research] but" other diseases as well, Peterlin said. "If you attenuate the activity of P-TEFb, you might be able to [develop] a non-gene-modifying way treat a lot of human diseases."

P.B. Rahl, et al., "c-Myc regulates transcriptional pause release," Cell:141,1-14,2010.








787   Gene Editing Treats Blood Disease  이성욱 2011/07/16 3065
786   A pathogenic picornavirus acquires an envelope by hijacking cellular membranes  이성욱 2013/04/23 3056
785   The Sugar Lnc  이성욱 2012/05/10 3036
784   A targeted cancer therapy? - small conditional RNA  이성욱 2010/09/08 3021
  More support for transcription trickPosted by Jef Akst  이성욱 2010/05/01 3003
782   Roche hepatitis C drug appears safe in combination  이성욱 2010/10/17 3002
781   면역 시스템을 가지는 바이러스  이성욱 2013/03/01 2992
780   유전자 특허 불인정 판결의 후폭풍: 멘붕에 빠진 미 BT 업계  이성욱 2013/06/20 2984
779   배아 발달 동안 돌연변이와 성인에서 암 발병 관련성  이성욱 2012/06/18 2983
778   Hepatitis C Virus Infection Linked to Fat Enzyme in Liver Cells  이성욱 2010/10/15 2978
777   Sugars recruited in fight against persistent infections  이성욱 2011/05/17 2966
776   Gene Therapy Appears to Help Patient With Anemia  이성욱 2010/09/17 2963
775   Viruses in the gut protect from infection  이성욱 2013/05/22 2947
774   Molecular scalpel hope for Duchenne muscular dystrophyBy James Gallagher  이성욱 2011/07/28 2942
773   Pluripotency not required !!!  이성욱 2010/01/28 2939
772   Autistic Mice Act a Lot Like Human Patients: Geneticists Develop Promising Mouse Model for Testing New Autism Therapies  이성욱 2011/10/06 2935
771   C형간염 진단 유전자검사 개발  이성욱 2013/03/07 2923
770   Why brain tumors hard to treat  이성욱 2010/11/23 2923
769   줄기세포 이식으로 HIV 감염 완치: 세계 3번째, 4번째의 HIV 완치 환자 등장  이성욱 2013/07/05 2911
768   More support for RNAi in clinic  이성욱 2010/03/23 2909

[이전 10개] [1]..[21][22][23][24] 25 [26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN